Key Finding
A multi-strain probiotic combination of Bifidobacterium, Lacticaseibacillus, Lactobacillus, and Streptococcus (Mix10) produced the greatest weight reduction versus placebo (MD: -2.83 kg) and also improved HDL cholesterol levels in patients with obesity across a network meta-analysis of 47 randomized controlled trials.
Can Probiotics Help with Weight Loss? Here's What the Latest Research Says
If you've been struggling with your weight, you may have heard buzz about probiotics — the beneficial bacteria found in fermented foods and supplements. A new scientific review published in Nutrition Reviews took a deep dive into whether specific probiotic combinations can actually help people with obesity lose weight and improve their cholesterol levels.
Researchers analyzed 47 studies involving 3,555 participants, comparing 26 different probiotic formulations against placebo treatments. They found that two specific multi-strain probiotic blends stood out from the rest. A combination called Mix10 — containing four types of beneficial bacteria including Bifidobacterium, Lacticaseibacillus, Lactobacillus, and Streptococcus — led to an average weight reduction of nearly 3 kg (about 6.5 lbs) compared to placebo. A second blend, Mix12, combining Bifidobacterium, Lactiplantibacillus, and Lactobacillus, also showed meaningful weight reduction of over 2 kg. Mix10 additionally helped raise HDL ("good") cholesterol levels, which is important for heart health.
What does this mean for you? These findings suggest that not all probiotics are created equal — the specific combination of bacterial strains matters significantly. While the research is promising, the authors noted the evidence is only low to moderate in certainty, meaning more high-quality studies are still needed.
For those exploring holistic approaches to weight management, acupuncture and Traditional Chinese Medicine (TCM) offer complementary strategies that may work alongside dietary and probiotic interventions to support metabolism, reduce inflammation, and address the root causes of weight gain according to TCM principles.
If you're curious about integrating these approaches into your wellness plan, speak with a qualified, licensed acupuncture practitioner in your area.
This systematic review and network meta-analysis (n=3,555; 47 RCTs) evaluated 26 probiotic formulations — 8 single-genus and 18 multi-genus — for efficacy in obesity management, measuring body weight and serum lipid outcomes via random-effects modeling with GRADE certainty assessment.
Key findings: Mix10 (Bifidobacterium, Lacticaseibacillus, Lactobacillus, Streptococcus) demonstrated the greatest weight reduction vs. placebo (MD: -2.83 kg; 95% CI: -4.33 to -1.32) and ranked highest for HDL-C improvement (MD: +0.20 mmol/L; 95% CI: 0.12 to 0.29). Mix12 (Bifidobacterium, Lactiplantibacillus, Lactobacillus) also ranked highly for weight reduction (MD: -2.14 kg; 95% CI: -3.13 to -1.15). Evidence certainty was rated low to moderate.
Clinical takeaway: Multi-strain probiotic formulations, particularly those combining Bifidobacterium and Lactobacillus genera, show clinically relevant effects on adiposity and lipid metabolism. Practitioners integrating TCM with nutritional protocols may consider multi-genus probiotic adjuncts as part of a comprehensive obesity management strategy pending higher-certainty trial confirmation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Body acupuncture combined with conventional treatment produced the greatest improvements in fasting blood glucose and HbA1c in type 2 diabetes patients, while auricular acupuncture best reduced postprandial blood glucose and laser acupuncture most effectively improved insulin resistance across 139 randomized controlled trials.
📌 Combining plum-blossom needling with Western medicine produced a significantly higher rate of symptom improvement in alopecia areata patients compared to Western medicine alone (RR 1.09, 95% CI 1.03–1.16), though evidence certainty was rated low.
📌 Following discontinuation of GLP-1 receptor agonists, patients experienced significant rebound in weight (mean +4.13 kg), waist circumference, and HbA1c, suggesting that continuous treatment is likely required to sustain clinically meaningful metabolic benefits.